壳聚糖/pcDNA-DPV-gC基因在雏鸭体内的抗原表达和分布

doi:10.3864/j.issn.0578-1752.2011.18.023

摘要/Abstract

摘要： 【目的】以DPV gC基因疫苗（pcDNA-DPV-gC）为模型，采用复凝法制备壳聚糖/pcDNA-DPV-gC纳米微球，对其在雏鸭体内的抗原表达和分布进行初步研究。【方法】将壳聚糖/pcDNA-DPV-gC基因疫苗以肌注、滴鼻和口服3种途径免疫20日龄雏鸭，于免疫后不同时间点（4h、12h、1d、3d、5d、7d、2 w、4 w、6 w和10 w）分别随机宰杀2只雏鸭，采集肝、脾、肺、肾、胰、脑、胸腺、哈氏腺、法氏囊、食道、十二指肠、盲肠和直肠，应用间接免疫组化检测DPV gC基因在雏鸭体内的抗原表达和分布。【结果】①肌注组免疫雏鸭1 d，肝脏、法氏囊、十二指肠、盲肠和直肠检测到DPV gC蛋白；滴鼻组免疫雏鸭12 h，肺脏出现阳性信号，1 d哈氏腺和法氏囊检测到DPV gC蛋白；口服组免疫雏鸭12 h，食道出现中等强度的阳性信号，1 d法氏囊、十二指肠、盲肠和直肠检测到DPV gC蛋白；②在3种免疫途径中，肝脏、肺脏、法氏囊、哈氏腺、食道、十二指肠、盲肠和直肠是DPV gC抗原表达的主要器官；阳性信号主要在肝细胞、肺上皮细胞、法氏囊和哈氏腺淋巴细胞、食道上皮细胞和肠道粘膜上皮细胞及固有层细胞等部位；③不同免疫途径免疫的壳聚糖/pcDNA-DPV-gC基因疫苗在雏鸭体内的抗原表达量和持续时间的总体表达规律为：肌注组＞滴鼻组＞口服组。【结论】壳聚糖能促进DPV gC基因在雏鸭体内的表达和分布，肌肉注射是壳聚糖/pcDNA-DPV-gC基因疫苗首选的免疫方式。

关键词: 壳聚糖, 壳聚糖/pcDNA-DPV-gC基因, 抗原表达, 分布

Abstract: 【Objective】 DNA-chitosan nanoparticles carrying duck plague virus (DPV) gC gene were constructed by using complex coacervation process to investigate its antigenic expression and distribution in the vaccinated ducklings. 【Method】 The 20-day-old DPV-free ducklings were respectively immunized with chitosan/pcDNA-DPV-gC gene vaccine via intramuscular injection, nasal administration and oral administration. At intervals of 4 h, 12 h, 1 d, 3 d, 5 d, 7 d, 2 w, 4 w, 6 w and 10 w post-vaccination (p.v.), two ducklings were randomly euthanatized and their organs (liver, spleen, lung, kidney, pancreas, brain, thymus, Harderian gland, bursa of Fabricius, esophagus, duodenum, caecum, and rectum) were collected. Meanwhile, an indirect immunohistochemical staining (IHC) was developed to detect antigenic expression and distribution of DPV gC antigens in the vaccinated ducklings. 【Result】 The DPV gC proteins were found in the liver, bursa of Fabricius, duodenum, caecum and rectum in the intramuscular injection group at 1 d post-vaccination (p.v.); Moreover, the immunogenicity were firstly found in the lung at 12 h p.v., and the DPV gC proteins were observed in the bursa of Fabricius and Harderian gland in the nasal administration group at 1 d p.v. Furthermore, the positive signals were firstly found in the esophagus at 12 h p.v., and the DPV gC proteins were observed in the bursa of Fabricius, duodenum, caecum and rectum in the oral administration group at 1 d p.v.. The DPV gC proteins were distributed in the liver, lung, bursa of Fabricius, Harderian gland, esophagus, duodenum, caecum and rectum, which were served as the principal sites for DPV gC antigens localization. The positive immunogenicity was mainly distributed in the parenchymal hepatic cells, epithelial cells of lung, lymphocytes of Harderian gland and bursa of Fabricius, epithelial cells of esophagus, epithelial cells and lamina propria mucosae cells of intestinal tract. According to the immunogenicity intensity and duration time via different immunization routes, the positive staining in all tissues was in the order of intramuscular injection group＞nasal administration group＞oral administration group. 【Conclusion】 The results demonstrated that chitosan as a polycationic gene carrier could promote the expression efficiency of DPV gC antigens in the vaccinated ducklings. Intramuscular injection was considered to be the best immunization routes to inoculated chitosan/pcDNA- DPV-gC gene vaccine.

Key words:

chitosan, chitosan/pcDNA-DPV-gC gene , antigenic expression, distribution

沈福晓, 蒋金凤, 程安春, 汪铭书, 路立婷, 贾仁勇, 朱德康, 陈孝跃, 孙涛. 壳聚糖/pcDNA-DPV-gC基因在雏鸭体内的抗原表达和分布[J]. 中国农业科学, 2011, 44(18): 3909-3917.

SHEN Fu-Xiao, JIANG Jin-Feng, CHENG An-Chun, WANG Ming-Shu, LU Li-Ting, JIA Ren-Yong, ZHU De-Kang, CHEN Xiao-Yue, SUN Tao. Antigenic Expression and Distribution of Chitosan/pcDNA-DPV-gC Gene in the Vaccinated Ducklings[J]. Scientia Agricultura Sinica, 2011, 44(18): 3909-3917.

0
/ / 推荐

导出引用管理器 EndNote|Reference Manager|ProCite|BibTeX|RefWorks

链接本文: https://www.chinaagrisci.com/CN/10.3864/j.issn.0578-1752.2011.18.023

https://www.chinaagrisci.com/CN/Y2011/V44/I18/3909

参考文献

[1]Converse K A, Kidd G A. Duck plague epizootics in the United States, 1967-1995. Journal of Wildlife Diseases, 2001, 37 (2): 347-357.

[2]Guo Y F, Cheng A C, Wang M S, Zhou Y. Purification of anatid herpesvirus 1 particles by tangential-flow ultrafiltration and sucrose gradient ultracentrifugation. Journal of Virological Methods, 2009, 161 (1): 1-6.

[3]Lian B, Xu C, Cheng A C, Wang M S, Zhu D K, Luo Q H, Jia R Y, Bi F J, Chen Z L, Zhou Y, Yang Z X, Chen X Y. Identification and characterization of duck plague virus glycoprotein C gene and gene product. Virology Journal, 2011, 7:349.

[4]Zou Q, Sun K F, Cheng A C, Wang M S, Xu C, Zhu D K, Jia R Y, Luo Q H, Zhou Y, Chen Z L, Chen X Y. Detection of anatid herpesvirus 1 gC gene by TaqManTM fluorescent quantitative real-time PCR with specific primers and probe. Virology Journal, 2010, 7:37.

[5]Herold B C, WuDunn D, Soltys N, Spear P G. Glycoprotein C of herpes simplex virus type 1 plays a principal role in the adsorption of virus to cells and in infectivity. Journal of Virology, 1991, 65 (3):1090-1098.

[6]Azab W, Tsujimura K, Maeda K, Kobayashi K, Mohamed Y M, Kato K, Matsumura T, Akashi H. Glycoprotein C of equine herpesvirus 4 plays a role in viral binding to cell surface heparan sulfate. Virus Research, 2010, 151(1):1-9.

[7]Osorio Y, Cohen J, Ghiasi H. Improved protection from primary ocular HSV-1 infection and establishment of latency using multigenic DNA vaccines. Investigative Ophthalmology & Visual Science, 2004, 45 (2): 506-514.

[8]Xiao S B, Chen H C, Fang L R, Liu C S, Zhang H, Jiang Y B, Hong W Z. Comparison of immune responses and protective efficacy of suicidal DNA vaccine and conventional DNA vaccine encoding glycoprotein C of pseudorabies virus in mice. Vaccine, 2004, 22 (3-4): 345-351.

[9]Liu F Y, Ma B, Zhao Y, Zhang Y, Wu Y H, Liu X M, Wang J W. Characterization of the gene encoding glycoprotein C of duck enteritis virus. Virus Genes, 2008, 37 (3): 328-332.

[10]Sato T, Ishii T, Okahata Y. In vitro gene delivery mediated by chitosan. effect of pH, serum, and molecular mass of chitosan on the transfection efficiency. Biomaterials, 2001, 22 (15): 2075-2080.

[11]Lee J I, Ha K S, Yoo H S. Quantum-dot-assisted fluorescence resonance energy transfer approach for intracellular trafficking of chitosan/DNA complex. Acta Biomaterialia, 2008, 4 (4):791-798.

[12]Shen F X, Ma G P, Cheng A C, Wang M S, Li C F, Sun K F, Chang H, Zhu D K, Jia R Y, Chen X Y, Sun T. Development and application of an indirect immunohistochemical method for the detection of duck plague virus vaccine antigens in paraffin sections and localization in the vaccinated duckling tissues. Poultry Science, 2010, 89 (9): 1915-1923.

[13]黎敏, 朱德康, 卢菲, 韩新峰, 程安春, 汪铭书, 刘晓东, 车茜, 陈孝跃. 不同剂量小鹅瘟病毒VP3基因疫苗在雏鹅体内的表达时相和分布规律. 中国兽医科学, 2008, 38 (6): 514-520.

Li M, Zhu D K, Lu F, Han X F, Cheng A C, Wang M S, Liu X D, Che Q, Chen X Y. Distribution and expression kinetics of different doses of GPV-VP3 DNA vaccine in gosling. Chinese Veterinary Science, 2008, 38 (6): 514-520. (in Chinese)

[14]徐超, 程安春, 汪铭书, 文明, 刘菲, 韩晓英, 宋涌, 廖永洪, 陈孝跃. 间接酶免疫组化检测DPV在感染鸭体内细胞定位的研究和应用. 中国兽医学报, 2007, 27 (5): 640-644.

Xu C, Cheng A C, Wang M S, Wen M, Liu F, Han X Y, Song Y, Liao Y H, Chen X Y. Study and application on cellular localization of DPV antigens in infected ducks by indirect immunoperoxidase technique. Chinese Journal of Veterinary Science, 2007, 27 (5): 640-644. (in Chinese)

[15]张文龙, 殷喆, 刘霓虹, 杨涛, 刘胜旺, 步志高, 王君伟, 吴东来. 鸡白细胞介素2（IL-2）DNA-壳聚糖纳米粒的制备及体外转染. 农业生物技术学报, 2009, 17 (4): 547-553.

Zhang W L, Yin Z, Liu N H, Liu T, Liu S W, Bu Z G, Wang J W, Wu D L. Preparation of chicken interleukin-2 (IL-2) DNA-chitosan nanoparticles and its transfection in vitro. Journal of Agricultural Biotechnology, 2009, 17 (4): 547-553. (in Chinese)

[16]Ishii T, Okahata Y, Sato T. Mechanism of cell transfection with plasmid/chitosan complexes. Biochimica et Biophysica Acta, 2001, 1514 (1): 51-64.

[17]Liu W G, Sun S J, Cao Z Q, Zhang X, Yao K D, Lu W W, Luk K K D. An investigation on the physicochemical properties of chitosan/ DNA polyelectrolyte complexes. Biomaterials, 2005, 26(15): 2705-2711.

[18]Zheng F, Shi X W, Yang G F, Gong L L, Yuan H Y, Cui Y J, Wang Y, Du Y M, Li Y. Chitosan nanoparticle as gene therapy vector via gastrointestinal mucosa administration: results of an in vitro and in vivo study. Life Sciences, 2007, 80 (4): 388-396.

[19]Zhang X L, Yu C L, Shi X, Zhang C, Tang T T, Dai K R. Direct chitosan-mediated gene delivery to the rabbit knee joints in vitro and in vivo. Biochemical and Biophysical Research Communications, 2006, 341 (1): 202-208.

[20]Koping-Hoggard M, Tubulekas I, Guan H, Edwards K, Nilsson M, Varum K M, Artursson P. Chitosan as a nonviral gene delivery system. Structure-property relationships and characteristics compared with polyethylenimine in vitro and after lung administration in vivo. Gene Therapy, 2001, 8 (14): 1108-1121.

[21]沈福晓, 程安春, 汪铭书, 蒋金凤, 贾仁勇, 朱德康, 陈孝跃, 孙涛, 杨金龙. 不同剂量鸭瘟病毒gC基因疫苗在雏鸭体内的抗原表达时相和分布规律. 畜牧兽医学报, 2010, 41 (6): 726-734.

Shen F X, Cheng A C, Wang M S, Jiang J F, Jia R Y, Zhu D K, Chen X Y, Sun T and Chen J L. Antigenic distribution and expression regularity in the different doses of pcDNA-DPV-gC DNA vaccine in Tianfu ducklings. Acta Veterinaria et Zoontechnica Sinica, 2010, 41 (6):726-734. (in Chinese)

[22]Mansouri S, Lavigne P, Corsi K, Benderdour M, Beaumont E, Fernandes J C. Chitosan-DNA nanoparticles as non-viral vectors in gene therapy: strategies to improve transfection efficacy. European Journal of Pharmaceutics and Biopharmaceutics, 2004, 57 (1): 1-8.

[23]Chen J, Yang W L, Li G, Qian J, Xue J L, Fu S K, Lu D R. Transfection of mEpo gene to intestinal epithelium in vivo mediated by oral delivery of chitosan-DNA nanoparticles. World Journal of Gastroenterology, 2004, 10 (1): 112-116.

[24]Kumar M, Behera A K, Lockey R F, Zhang J, Bhullar G, De La Cruz C P, Chen L C, Leong K W, Huang S K, Mohapatra S S. Intranasal gene transfer by chitosan-DNA nanospheres protects BALB/c mice against acute respiratory syncytial virus infection. Human Gene Therapy, 2002, 13 (12): 1415-1425.

[25]Ozbas-Turan S, Aral C, Kabasakal L, Keyer-Uysal M, Akbuga J. Co-encapsulation of two plasmids in chitosan microspheres as a non-viral gene delivery vehicle. Journal of Pharmacy and Pharmaceutical Sciences, 2003, 6 (1): 27-32.